Evidence map›Paper›PMID 35218313›Full record

ArticleJournal of cachexia, sarcopenia and muscle2022

Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop.

Jose M Garcia, Richard F Dunne, Kristen Santiago, Lisa Martin, Morris J Birnbaum, Jeffrey Crawford, Andrew E Hendifar, Martin Kochanczyk, Cassadie Moravek, Doris Piccinin and 4 more

Abstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Cancer cachexia: a caregiver and advocate perspective.Current opinion in supportive and palliative care · 2026
    Review
  3. Article
  4. Addressing the distressing: Pancreatic enzyme replacement therapy mitigates abdominal symptoms and weight loss during chemotherapy for advanced pancreatic cancer: A prospective study.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Targeting Gut Microbiota in Cancer Cachexia: Towards New Treatment Options.International journal of molecular sciences · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jose M GarciaDepartment of Medicine, Division of Geriatrics, University of Washington and Geriatric Research Education and Clinical Center, Puget Sound Veterans Administration Health Care System, Seattle, WA, USA.
Richard F DunneWilmot Cancer Institute, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Kristen SantiagoLUNGevity Foundation, Bethesda, MD, USA.
Lisa MartinDepartment of Medicine, University of Alberta, Edmonton, AB, Canada.
Morris J BirnbaumInternal Medicine Research Unit, Pfizer Inc., Cambridge, MA, USA.
Jeffrey CrawfordDepartment of Medicine, Duke University School of Medicine, Durham, NC, USA.
Andrew E HendifarCedars Sinai, Los Angeles, CA, USA.
Martin KochanczykPattern Bioscience, Austin, TX, USA.
Cassadie MoravekPancreatic Cancer Action Network, Manhattan Beach, CA, USA.
Doris PiccininAbramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Vincent PicozziVirginia Mason Medical Center, Seattle, WA, USA.
Eric J RoelandKnight Cancer Institute, Oregon Health and Sciences University, Portland, OR, USA.
Wendy K D SeligWSCollaborative, McLean, VA, USA.
Teresa A ZimmersDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.ORCID 0000-0001-7872-0540

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
The role of the macroenvironment in pancreatic cancer-induced cachexiaP01CA236778 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI NEELON, BRIAN · 2021 to 2025
$9.7M
The Role of Ghrelin and the GHSR-1a receptor in Sarcopenic ObesityI01BX002807 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · PI GARCIA, JOSE M. · 2016 to 2025
–
Molecular Mechanisms of Muscle and Fat Wasting in Pancreatic Cancer CachexiaI01BX004177 · VA · RLR VA MEDICAL CENTER · PI ZIMMERS, TERESA A · 2018 to 2021
–
Tumor tissue crosstalk in the macroenvironment of pancreatic cancer cachexiaI01CX002046 · VA · RLR VA MEDICAL CENTER · PI ZIMMERS, TERESA A · 2020 to 2024
–
BLRD VA I01 BX002807BLRD VA I01 BX004177CSRD VA I01 CX002046NCI NIH HHS P01 CA236778NCI NIH HHS UG1 CA189961Pfizer, Inc
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CachexiaNeoplasmsHumansSurveys and QuestionnairesCachexiaCancerCholangiocarcinomaColorectal cancerCongressLung cancerNutritionPancreatic cancerSupportive care

Identifiers

PMID35218313
PMCPMC8978010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.